Document:

Exhiit 10.2

                        TECHNOLOGY ACQUISITION AGREEMENT

     This Technology Acquisition Agreement (the "AGREEMENT") is made and entered
into this ___ day of July, 2012, by and between Technew Technology Limited, a
company incorporated under the companies ordinance of Hong Kong ("TECHNEW"), and
Stevia Corp., a Nevada corporation (the "COMPANY"). The parties hereto agree as
follows:

                                    AGREEMENT

     1. TECHNOLOGY TRANSFERRED. TechNew hereby irrevocably assigns, sells,
transfers and conveys to the Company all of TechNew's right, title and interest,
on a worldwide basis, in and to the technology described in Attachment 1 hereto,
and all applicable intellectual property rights, on a worldwide basis, related
thereto, including, without limitation, copyrights, trademarks, trade secrets,
patents, patent applications, moral rights, contract and licensing rights
(collectively, the "PROPERTY"). TechNew hereby acknowledges that it retains no
right to use the Property and agrees not to challenge the validity of the
Company's ownership of the Property.

     2. SHARE CONSIDERATION. In consideration for such transfer of the Property,
TechNew will receive 3,000,000 shares of the Company's common stock (the
"SHARES"). Within seven (7) days after the date hereof, the Company shall
deliver to TechNew a stock certificate representing the Shares registered in the
name of TechNew.

     (a) REPRESENTATIONS OF COMPANY RELATING TO THE SHARES. The Company has all
requisite power and authority to execute, deliver and perform its obligations
under this Agreement, and this Agreement has been duly authorized and validly
executed and delivered by the Company and constitute legal, valid and binding
agreement of the Company enforceable against the Company in accordance with
their terms, except as rights to indemnity and contribution may be limited by
state or federal securities laws or the public policy underlying such laws,
except as enforceability may be limited by applicable bankruptcy, insolvency,
reorganization, moratorium or similar laws affecting creditors' and contracting
parties' rights generally and except as enforceability may be subject to general
principles of equity (regardless of whether such enforceability is considered in
a proceeding in equity or at law). No further approval or authorization of any
stockholder, the Board of Directors of the Company or others is required for the
issuance and sale of the Shares. The Shares being acquired hereunder will, upon
issuance and payment therefore pursuant to the terms hereof, be duly authorized,
validly issued, fully-paid and nonassessable

     (b) REPRESENTATIONS OF TECHNEW RELATING TO THE SHARES. Concurrently with
the execution of this Agreement, TechNew will execute and deliver to the Company
the Shareholder Representation Letter in the form attached hereto as Attachment
2.

     3. FURTHER ASSURANCES. Upon each request by the Company, without additional
consideration, TechNew agrees to promptly execute documents, testify and take
other acts at the Company's expense as the Company may deem necessary or
desirable to procure, maintain, perfect, and enforce the full benefits,
enjoyment, rights, title and interest, on a worldwide basis of the Property
assigned hereunder, and render all necessary assistance in making application
for and obtaining original, divisional, renewal, or reissued utility and design
patents, copyrights, mask works, trademarks, trade secrets, and all other
technology and intellectual property rights throughout the world related to any
of the Property, in the Company's name and for its benefit. In the event the
<PAGE>
Company is unable for any reason, after reasonable effort, to secure TechNew's
signature on any document needed in connection with the actions specified
herein, TechNew hereby irrevocably designates and appoints the Company and its
duly authorized officers and agents as its agent and attorney in fact, which
appointment is coupled with an interest, to act for and in its behalf to
execute, verify and file any such documents and to do all other lawfully
permitted acts to further the purposes of this paragraph with the same legal
force and effect as if executed by TechNew. TechNew hereby waives and quitclaims
to the Company any and all claims, of any nature whatsoever, which TechNew now
or may hereafter have for infringement of any Property assigned hereunder.

     4. DELIVERY OF TANGIBLE PROPERTY. TechNew further agrees to deliver to the
Company upon execution of this Agreement any and all tangible manifestations of
the Property, including, without limitation, all notes, records, files and
tangible items of any sort in its possession or under its control relating to
the Property. Such delivery shall include all present and predecessor versions.

     5. REPRESENTATIONS AND WARRANTIES OF TECHNEW RELATING TO THE PROPERTY.
TechNew represents and warrants to the Company that (a) TechNew is the sole
owner of the Property and has full and exclusive right to assign the rights
assigned herein, (b) TechNew has full right and power to enter into and perform
this Agreement without the consent of any third party, (c) all of the Property
is free and clear of all claims, liens, encumbrances and the like of any nature
whatsoever, (d) the Property is an original work of TechNew, (e) none of the
Property infringes, conflicts with or violates any patent or other intellectual
property right of any kind (including, without limitation, any trade secret) or
similar rights of any third party, (f) TechNew was not acting within the scope
of employment or other service arrangements with any third party when
conceiving, creating or otherwise performing any activity with respect to the
Property, (g) the execution, delivery and performance of this Agreement does not
conflict with, constitute a breach of, or in any way violate any arrangement,
understanding or agreement to which TechNew is a party or by which TechNew is
bound, and (h) TechNew has maintained the Property in confidence and has not
granted, directly or indirectly, any rights or interest whatsoever in the
Property to any third party. TechNew further represents and warrants to the
Company that no claim, whether or not embodied in an action past or present, of
any infringement, of any conflict with, or of any violation of any patent, trade
secret or other intellectual property right or similar right, has been made or
is pending or threatened against TechNew relative to the Property. TechNew
agrees to promptly inform the Company of any such claim arising or threatened in
the future with respect to the Property or any part thereof.

     6. INDEMNIFICATION. TechNew will indemnify and hold harmless the Company,
from any and all claims, losses, liabilities, damages, expenses and costs
(including attorneys' fees and court costs) which result from a breach or
alleged breach of any representation , warranty or covenant of TechNew (a
"CLAIM") set forth in this Agreement, provided that the Company gives TechNew
written notice of any such Claim and TechNew has the right to participate in the
defense of any such Claim at its expense.

     7. MISCELLANEOUS. This Agreement and the Attachment attached hereto
constitute the entire, complete, final and exclusive understanding and agreement
of the parties hereto with respect to the subject matter hereof, and supersedes
any other prior or contemporaneous oral understanding or agreement or any other
prior written agreement. No modification of or amendment to this Agreement, nor
any waiver of any rights under this Agreement, will be effective unless in
writing and signed by the parties hereto. This Agreement will be governed and
construed in accordance with the laws of the State of Nevada. If any provision
of this Agreement is found invalid or unenforceable, in whole or in part, the
remaining provisions and partially enforceable provisions will, nevertheless, be

                                       2
<PAGE>
binding and enforceable. Failure by either party to exercise any of its rights
hereunder shall not constitute or be deemed a waiver or forfeiture of such
rights. The provisions hereof shall inure to the benefit of, and be binding
upon, the successors, assigns, heirs, executors and administrators of the
parties hereto.

                            [SIGNATURE PAGE FOLLOWS]

                                       3
<PAGE>
     In Witness Whereof, the undersigned have executed this Technology
Acquisition Agreement as of the date set forth above.

STEVIA CORP.                                  TECHNEW TECHNOLOGY LIMITED

By:                                           By:
   -------------------------------               -------------------------------

Print Name:                                   Print Name:
           -----------------------                       -----------------------

Title:                                        Title:
      ----------------------------                  ----------------------------

                                       4exh_43.htm

EXHIBIT 4.3

 

 

 

 

NEPTUNE TECHNOLOGIES & BIORESSOURCES INC.

 

STOCK OPTION PLAN

AS AMENDED AND RESTATED MAY 9, 2012

 

 

 

 

 

  

  

  

NEPTUNE TECHNOLOGIES & BIORESSOURCES INC.

 

STOCK OPTION PLAN

 

THIS PLAN adopted May 10, 2001, amended October 1, 2002; August 28, 2003; June 14, 2005; April 20, 2006; April 29, 2009; May 6, 2010; March 21, 2011; May 25, 2011 and May 9, 2012.

 

ARTICLE 1

DEFINITIONS AND INTERPRETATION

 

1.1 Definitions.  Where used in this Plan, unless there is something in the subject matter or context inconsistent therewith, the following terms will have the meanings set forth below:

 

	
(a)  

	
“Acasti” means Acasti Pharma Inc., a Subsidiary of the Corporation

 

	
(b)  

	
"Associate" has the meaning ascribed to it in the Securities Act.

 

	
(c)  

	
"Board" means the board of directors of the Corporation, or any duly appointed committee thereof to which the board of directors of the Corporation has delegated the power to administer and grant Options under this Plan, as constituted from time to time.

 

	
(d)  

	
"Cause" means, with respect to a particular Employee:

 

	 	
(i) 

	
"cause" as such term is defined in the written employment agreement between the Corporation and the Employee; or

 

	 	
(ii) 

	
in the event there is no written employment agreement between the Corporation and the Employee or "cause" is not defined in the written employment agreement between the Corporation and the Employee, the usual meaning of cause under the laws of the Province of Québec.

 

	
(e)  

	
“Code” has the meaning given in Section 7.1 of this Plan.

 

	
(f)  

	
"Company" means, unless specifically indicated otherwise, a corporation, incorporated association or organization, body corporate, partnership, trust, association, or other entity other than an individual.

 

	
(g)  

	
"Consultant" means a person, other than an Employee or Director of the Corporation, or a Company, who:

 

	 	
(i) 

	
provides on a bona fide basis consulting, technical, management or other services to the Corporation or a Subsidiary of the Corporation under a written contract;

 

  

  

  

 

	 	
(ii) 

	
possesses technical, business, management or other expertise of value to the Corporation or a Subsidiary of the Corporation;

 

	 	
(iii) 

	
in the reasonable opinion of the Corporation, spends or will spend a significant amount of time and attention on the business and affairs of the Corporation or a Subsidiary of the Corporation; and

 

	 	
(iv) 

	
has a relationship with the Corporation or a Subsidiary of the Corporation that enables the individual to be knowledgeable about the business and affairs of the Corporation.

 

	
(h)  

	
"Corporation" means Neptune Technologies & Bioressources Inc., and includes any successor corporation thereto.

 

	
(i)  

	
"Director" means a member of the board of directors of the Corporation or a member of the board of directors of a Subsidiary of the Corporation to whom stock options may be granted in reliance on a prospectus exemption under applicable Securities Laws.

 

	
(j)  

	
"Effective Date" means the effective date of this Plan, as amended, being May 9, 2012.

 

	
(k)  

	
"Employee" means an individual who:

 

	 	
(i) 

	
is considered an employee of the Corporation or a Subsidiary of the Corporation under the Income Tax Act (Canada) (i.e., for whom income tax, employment insurance and CPP deductions must be made at source);

 

	 	
(ii) 

	
works full-time for the Corporation or a Subsidiary of the Corporation providing services normally provided by an employee and who is subject to the same control and direction by the Corporation or a Subsidiary of the Corporation over the details and methods of work as an employee of the Corporation, but for whom income tax deductions are not made at source; or

 

	 	
(iii) 

	
works for the Corporation or a Subsidiary of the Corporation on a continuing and regular basis for a minimum amount of time per week providing services normally provided by an employee and who is subject to the same control and direction by the Corporation or a Subsidiary of the Corporation over the details and methods of work as an employee of the Corporation, but for whom income tax deductions are not made at source.

 

	
(l)  

	
"Exchange" means the Toronto Stock Exchange and, where the context permits, any other exchange on which the Shares are or may be listed from time to time.

 

	
(m)  

	
"Exercise Notice" means the notice respecting the exercise of an Option, in the form set out in the Option Agreement, duly executed by the Option Holder.

 

  

- 2 -

  

 

	
(n)  

	
"Exercise Period" means the period during which a particular Option may be exercised and, subject to earlier termination in accordance with the terms hereof, is the period from and including the Grant Date through to and including the Expiry Date.

 

	
(o)  

	
"Exercise Price" means the price per Share at which Shares may be purchased under an Option duly granted under this Plan, as determined in accordance with Section 4.3 of this Plan and, if applicable, adjusted in accordance with Section 3.5 of this Plan.

 

	
(p)  

	
"Expiry Date" means the date determined in accordance with Section 4.2 of this Plan and after which a particular Option cannot be exercised and is deemed to be null and void and of no further force or effect.

 

	
(q)  

	
"Grant Date" means the date on which the Board grants a particular Option.

 

	
(r)  

	
"Insider" means an “insider” as defined by the Exchange from time to time in its rules and regulations governing Security Based Compensation Arrangements and other related matters.

 

	
(s)  

	
“ISOs” has the meaning given in Section 7.1 of this Plan.

 

	
(t)  

	
"Market Price" at any date in respect of the Shares shall be the closing price of such Shares on the Exchange (and if listed on more than one stock exchange, then the highest of such closing prices) on the last Business Day prior to the Grant Date (or, if such Shares are not then listed and posted for trading on the Exchange, on such stock exchange in Canada on which the Shares are listed and posted for trading as may be selected for such purpose by the Board). In the event that such Shares did not trade on such Business Day, the Market Price shall be the average of the bid and asked prices in respect of such Shares at the close of trading on such date. In the event that such Shares are not listed and posted for trading on any stock exchange, the Market Price shall be the fair market value of such Shares as determined by the Board in its sole discretion;

 

	
(u)  

	
“NeuroBio” means NeuroBioPharm Inc., a Subsidiary of the Corporation.

 

	
(v)  

	
“NeuroBio Option” means an option to acquire shares in the capital stock of NeuroBio pursuant to the NeuroBio Plan.

 

	
(w)  

	
“NeuroBio Plan” means the directors, employees and consultants stock option plan of NeuroBio dated as of May 25, 2011, as may be amended from time to time.

 

	
(x)  

	
"Option" means an option to acquire Shares granted to a Director, Employee or Consultant of the Corporation, Acasti, NeuroBio or any other Subsidiary of the Corporation pursuant to this Plan.

 

  

- 3 -

  

 

	
(y) 

	
"Option Agreement" means an agreement, in the form substantially similar as that set out in Schedule "A" hereto, evidencing an Option granted under this Plan.

 

	
(z)  

	
"Option Holder" means a Director, Employee or Consultant or former Director, Employee or Consultant, to whom an Option has been granted and who continues to hold an unexercised and unexpired Option or, where applicable, the Personal Representative of such person.

 

	
(aa)  

	
"Plan" means this stock option plan, as may be amended from time to time.

 

	
(bb)  

	
"Person" means a Company or an individual.

 

	
(cc)  

	
"Personal Representative" means:

 

	 	
(i) 

	
in the case of a deceased Option Holder, the executor or administrator of the deceased duly appointed by a court or public authority having jurisdiction to do so; and

 

	 	
(ii) 

	
in the case of an Option Holder who, for any reason, is unable to manage his or her affairs, the individual entitled by law to act on behalf of such Option Holder.

 

	
(dd)  

	
"QBCA" means the Business Corporations Act (Québec), as amended, or such other successor legislation which may be enacted, from time to time.

 

	
(ee)  

	
"Regulatory Authorities" means the Exchange and any other organized trading facilities on which the Corporation's Shares are listed and all securities commissions or similar securities regulatory bodies having jurisdiction over the Corporation.

 

	
(ff)  

	
"Re-Organization Event" has the meaning given in Section 3.5 of this Plan.

 

	
(gg)  

	
"Securities Act" means the Securities Act (Québec), as amended, or such other successor legislation as may be enacted, from time to time.

 

	
(hh)  

	
"Securities Laws" means securities legislation, securities regulation and securities rules, as amended, and the policies, notices, instruments and blanket orders in force from time to time that govern or are applicable to the Corporation or to which it is subject, including, without limitation, the Securities Act.

 

	
(ii)  

	
“Security Based Compensation Arrangement” has the meaning ascribed in Section 613(b) of the Toronto Stock Exchange Company Manual, and includes:

 

	 	
(i) 

	
stock option plans for the benefit of employees, insiders, service providers or any one of such groups;

 

  

- 4 -

  

 

	 	
(ii) 

	
individual stock options granted to employees, service providers or insiders if not granted pursuant to a plan previously approved by the Corporation’s security holders;

 

	 	
(iii) 

	
stock purchase plans where the Corporation provides financial assistance or where the Corporation matches the whole or a portion of the securities being purchased;

 

	 	
(iv) 

	
stock appreciation rights involving issuances of securities from treasury;

 

	 	
(v) 

	
any other compensation or incentive mechanism involving the issuance or potential issuances of securities of the Corporation; and

 

	 	
(vi) 

	
security purchases from treasury by an employee, insider or service provider which is financially assisted by the Corporation by any means whatsoever;

 

	
(jj)  

	
"Share" means one (1) common share without par value in the capital stock of the Corporation as constituted on the Effective Date or, in the event of an adjustment contemplated by Section 3.5 of this Plan, such other shares or securities to which an Option Holder may be entitled upon the due exercise of an Option as a result of such adjustment.

 

	
(kk)  

	
"Subsidiary" means a subsidiary as defined in the QBCA.

 

	
(ll)  

	
"Termination Date" means:

 

	 	
(i) 

	
in the case of the resignation of the Option Holder as an Employee of the Corporation, the date that the Option Holder provides notice of his or her resignation as an Employee of the Corporation to the Corporation;

 

	 	
(ii) 

	
in the case of the termination of the Option Holder as an Employee of the Corporation by the Corporation for any reason other than death, the effective date of termination set out in the Corporation's notice of termination of the Option Holder as an Employee of the Corporation to the Option Holder;

 

	 	
(iii) 

	
in the case of the termination of the written contract of the Option Holder to provide consulting services to the Corporation, the effective date of termination set out in any notice provided by one of the parties to the written contract to the other party; or

 

	 	
(iv) 

	
the effective date of termination of a Director, Employee or Consultant pursuant to an order made by any Regulatory Authority having jurisdiction to so order.

 

	
(mm)  

	
“U.S. Taxpayer” has the meaning given in Section 7.1 of this Plan.

 

  

- 5 -

  

 

	
(nn)  

	
Choice of Law.  This Plan is established under and the provisions of this Plan will be subject to and interpreted and construed in accordance with the laws of the Province of Québec.

 

	
(oo)  

	
Headings.  The headings used herein are for convenience only and are not to affect the interpretation of this Plan.

 

ARTICLE 2

PURPOSE AND ADMINISTRATION

 

2.1 Purpose.  The purpose of this Plan is to provide the Corporation with a share-related mechanism to attract, retain and motivate qualified Directors, Employees and Consultants of the Corporation, Acasti, NeuroBio or any other Subsidiary of the Corporation, to reward such of those Directors, Employees and Consultants as may be granted Options under this Plan by the Board from time to time for their contributions toward the long term goals and success of the Corporation and to enable and encourage such Directors, Employees and Consultants to acquire Shares as long term investments and proprietary interests in the Corporation.

 

2.2 Administration.  This Plan will be administered by the Board. The Board may make, amend and repeal at any time and from time to time such regulations not inconsistent with this Plan as it may deem necessary or advisable for the proper administration and operation of this Plan and such regulations will form part of this Plan. The Board may delegate to any director or other senior officer or employee of the Corporation such administrative duties and powers as it may see fit.

 

2.3 Board Powers.  The Board shall have the power, where consistent with the general purpose and intent of this Plan and subject to the specific provisions of this Plan to, amongst other things:

 

	
(a)  

	
establish policies and to adopt rules and regulations for carrying out the purposes, provisions and administration of this Plan;

 

	
(b)  

	
interpret and construe this Plan and to determine all questions arising out of this Plan or any Option, and any such interpretation, construction or determination made by the Board shall be final, binding and conclusive for all purposes;

 

	
(c)  

	
determine the number of Shares reserved for issuance by each Option;

 

	
(d)  

	
determine the Exercise Price of each Option;

 

	
(e)  

	
determine the time or times when Options will be granted and exercisable;

 

	
(f)  

	
determine if the Shares which are issuable on the due exercise of an Option will be subject to any restrictions upon the due exercise of such Option; and

 

	
(g)  

	
prescribe the form of the instruments and certificates relating to the grant, exercise and other terms of Options.

 

  

- 6 -

  

2.4 Board Discretion.  The Board may, in its discretion, require as conditions to the grant or exercise of any Option that the Option Holder shall have:

 

	
(a)  

	
represented, warranted and agreed in form and substance satisfactory to the Corporation that the Option Holder is acquiring and will acquire such Option and the Shares to be issued upon the exercise thereof for his, her or its own account, for investment and not with a view to or in connection with any distribution, that the Option Holder has had access to such information as is necessary to enable him, her or it to evaluate the merits and risks of such investment and that the Option Holder is able to bear the economic risk of holding such Shares for an indefinite period;

 

	
(b)  

	
agreed to restrictions on transfer in form and substance satisfactory to the Corporation and to an endorsement on any option agreement or certificate representing the Shares making appropriate reference to such restrictions; and

 

	
(c)  

	
agreed to indemnify the Corporation in connection with the foregoing.

 

2.5 Board Requirements.  Any Option granted under this Plan shall be subject to the requirement that, if at any time counsel to the Corporation shall determine that the listing, registration or qualification of the Shares issuable upon due exercise of such Option upon any securities exchange or under any Securities Laws of any jurisdiction, or the consent or approval of Regulatory Authority, is necessary as a condition of, or in connection with, the grant or exercise of such Option or the issuance or purchase of Shares thereunder, such Option may not be accepted or exercised in whole or in part unless such listing, registration, qualification, consent or approval shall have been effected or obtained on conditions acceptable to the Board.  Nothing herein shall be deemed to require the Corporation to apply for or to obtain such listing, registration, qualification, consent or approval.

 

2.6 Interpretation.  The interpretation by the Board of any of the provisions of this Plan and any determination by it pursuant thereto will be final and conclusive and will not be subject to any dispute by any Option Holder.  No member of the Board or any individual acting pursuant to authority delegated by it hereunder will be liable for any action or determination in connection with this Plan made or taken in good faith and each member of the Board and each such individual will be entitled to indemnification with respect to any such action or determination in the manner provided for by the Corporation.

 

ARTICLE 3

GRANT OF OPTIONS

 

3.1 Board to Issue Shares.  The Shares to be issued to Option Holders upon the exercise of Options will be previously authorized but unissued Shares in the capital stock of the Corporation.

 

3.2 Participation.  The Board will, from time to time and in its sole discretion, determine (i) those Directors, Employees, Consultants (and, when applicable, to a Company wholly owned by any such Director, Employee or Consultant), if any, to whom Options are to be granted based upon certain participation criteria, which criteria include but are not limited to 

 

  

- 7 -

  

functions within the Corporation, Acasti, NeuroBio or any other Subsidiary of the Corporation, seniority or actual and future contributions to the success of to the Corporation, Acasti, NeuroBio or any other Subsidiary of the Corporation, and (ii) the number of Options to be granted to such Directors, Employees or Consultants. The Board may only grant options to an Employee or Consultant if such Employee or Consultant is a bona fide Employee or Consultant of the Corporation or a Subsidiary of the Corporation, as the case may be. The Board may, in its sole discretion, grant the majority of the Options to Insiders of the Corporation.  However, in no case will the grant of Options under this Plan, together with any proposed or previously existing Security Based Compensation Arrangement, result in (in each case, as determined on the Grant Date):

 

	
(a)  

	
the number of Shares issuable pursuant to stock options granted to Insiders exceeding ten percent (10%) of the Corporation's issued and outstanding Shares (on a non-diluted basis);

 

	
(b)  

	
the issuance to Insiders, within any twelve (12) month period, of a number of Shares exceeding in the aggregate ten percent (10%) of the Corporation's issued and outstanding Shares (on a non-diluted basis);

 

	
(c) 

	
the grant to any one (1) Insider, and such Insider's Associates, within any twelve (12) month period, Options reserving for issuance a number of Shares exceeding in the aggregate five percent (5%) of the Corporation's issued and outstanding Shares (on a non-diluted basis);

 

	
(d)  

	
the grant to any one (1) Person, within any twelve (12) month period, of Options reserving for issuance a number of Shares exceeding in the aggregate five percent (5%) of the Corporation’s issued and outstanding Shares (on a non-diluted basis);

 

	
(e)  

	
the grant to any one Consultant of the Corporation, Acasti, NeuroBio or any other Subsidiary, within any twelve (12) month period, of Options reserving for issuance a number of Shares exceeding in the aggregate two percent (2%) of the Corporation’s issued and outstanding Shares (on a non-diluted basis); or

 

	
(f)  

	
the grant to any one Employee of the Corporation, Acasti, NeuroBio or any other Subsidiary which provides investor relations services, within any twelve (12) month period, of Options reserving for issuance a number of Shares exceeding in the aggregate two percent (2%) of the Corporation’s issued and outstanding Shares (on a non-diluted basis).

 

Any entitlement to acquire Shares granted pursuant to this Plan or any other Share Compensation Agreement prior to the Option Holder becoming an Insider shall be excluded for the purposes of calculating the limits set out in Subsections 2.2(a), (b) and (c), above.

 

3.3 Number of Shares Reserved.  Subject to adjustment as provided for in Section 3.5 of this Plan and any subsequent amendment to this Plan, the number of Shares reserved for issuance and which will be available for purchase pursuant to Options granted under this Plan will equal 15% of the issued and outstanding Shares of the Corporation from time to time.  Subject to the provisions and restrictions of this Plan, if any Option is exercised, cancelled, 

 

  

- 8 -

  

expired or otherwise terminated for any reason whatsoever, the number of Shares in respect of which Option is exercised, cancelled, expired or otherwise terminated for any reason whatsoever, as the case may be, will ipso facto again be immediately available for purchase pursuant to Options granted under this Plan.

 

3.4 NeuroBio Plan.

 

	
(a)  

	
Notwithstanding the provisions of Section 3.3 above, any grant of NeuroBio Options pursuant to the terms and conditions of the NeuroBio Plan will reduce the number of Shares reserved for issuance and which will be available for purchase pursuant to Options granted under this Plan on the basis of one (1) Share for every NeuroBio Option granted pursuant to the NeuroBio Plan.

 

	
(b)  

	
Subject to the maximum number of Shares reserved for issuance as provided in Section 3.3 above, if any NeuroBio Option granted pursuant to the NeuroBio Plan is exercised, cancelled, expired or otherwise terminated for any reason whatsoever, an additional number of Shares corresponding to the number of shares of NeuroBio in respect of which NeuroBio Option is exercised, cancelled, expired or otherwise terminated for any reason whatsoever, as the case may be, will ipso facto again be available for purchase pursuant to Options granted under this Plan.

 

	
(c)  

	
This Section 3.4 will be deemed to be null and void and of no further force or effect as of the date the shares of NeuroBio are “exchange-traded securities”, as such term is defined in National Instrument 51-102 – Continuous Disclosure Obligations, subject to the prior approval of the Exchange.

 

3.5 Adjustments.  If, prior to the complete exercise of an Option, the Shares are consolidated, subdivided, converted, exchanged or reclassified or in any way substituted for (collectively, a "Re-Organization Event"), an Option, to the extent that it has not been exercised, will be adjusted by the Board in accordance with such Re-Organization Event in the manner the Board deems appropriate and equitable.  No fractional Shares will be issued upon the exercise of the Options and accordingly, if as a result of the Re-Organization Event, an Option Holder would become entitled to a fractional Share, such Option Holder will have the right to purchase only the next lowest whole number of Shares and no payment or other adjustment will be made with respect to the fractional interest so disregarded.

 

3.6 Notification of Grant.  Following the approval by the Board of the granting of an Option, the Board will notify the Option Holder in writing of the award and will enclose with such notice the Option Agreement representing the Option so granted.

 

3.7 Copy of Plan.  Each Option Holder, concurrently with the notice of the award of the Option, will, upon written request, be provided with a copy of this Plan, and a copy of any amendment to this Plan will be promptly provided by the Board to each Option Holder.

 

3.8 Limitation.  This Plan does not give any Option Holder that is a Director the right to serve or continue to serve as a Director of the Corporation, does not give any Option Holder that is an Employee the right to be or to continue to be employed by the Corporation and does 

 

  

- 9 -

  

not give any Option Holder that is a Consultant the right to be or continue to be retained or engaged by the Corporation as a consultant for the Corporation.

 

ARTICLE 4

TERMS AND CONDITIONS OF OPTIONS

 

4.1 Term of Option.  Subject to Section 4.2, the Expiry Date of an Option will be the date so fixed by the Board at the time the particular Option is granted, provided that such date will be no later than the fifth (5th) anniversary of the Grant Date of such Option.

 

4.2 Termination of Option.  Subject to such other terms or conditions that may be attached to Options granted hereunder, an Option Holder may exercise an Option in whole or in part at any time or from time to time during the Exercise Period.  Any Option or part thereof not exercised within the Exercise Period will terminate and become null, void and of no effect as of 5:00 p.m. (Montréal time) on the Expiry Date. The Expiry Date of an Option will be the earlier of the date so fixed by the Board at the time the Option is granted and the date established, if applicable, in subsections (a) to (c) below:

 

	
(a)  

	
Death of Option Holder

 

In the event that the Option Holder should die while he or she is still a Director (if he or she holds his or her Option as a Director), an Employee (if he or she holds his or her Option as an Employee) or a Consultant (if he or she holds his or her Option as a Consultant), the Expiry Date will be the first anniversary of the Option Holder's date of death.

 

	
(b)  

	
Ceasing to Hold Office

 

In the event that the Option Holder holds his or her Option as a Director of the Corporation and such Option Holder ceases to be a Director of the Corporation other than by reason of death, the Expiry Date of the Option will not exceed the sixtieth (60th) day following the date the Option Holder ceases to be a Director of the Corporation unless the Option Holder ceases to be a Director of the Corporation as a result of:

 

	 	
(i) 

	
ceasing to meet the qualifications of a director set forth the QBCA; or

 

	 	
(ii) 

	
an ordinary resolution having been passed by the shareholders of the Corporation pursuant to the QBCA; or

 

	 	
(iii) 

	
an order made by any Regulatory Authority having jurisdiction to so order,

 

in which case the Expiry Date will be the date the Option Holder ceases to be a Director of the Corporation.

 

  

- 10 -

  

 

	
(c)  

	
Ceasing to be an Employee or Consultant

 

In the event that the Option Holder holds his or her Option as an Employee or Consultant of the Corporation and such Option Holder ceases to be an Employee or Consultant of the Corporation other than by reason of death, the Expiry Date of the Option will not exceed the sixtieth (60th) day following the Termination Date or, if the Employee or Consultant provides investor relations services, the thirtieth (30th) day following the Termination Date, unless the Option Holder:

 

	 	
(i) 

	
ceases to be an Employee of the Corporation as a result of termination for Cause; or

 

	 	
(ii) 

	
ceases to be  an Employee or Consultant of the Corporation as a result of an order made by any Regulatory Authority having jurisdiction to so order,

 

in which case the Expiry Date will be the Termination Date.

 

	
(d)  

	
Bankruptcy

 

In the event that an Option Holder commits an act of bankruptcy or any proceeding is commenced against an Option Holder under the Bankruptcy and Insolvency Act (Canada) or other applicable bankruptcy or insolvency legislation in force at the time of such bankruptcy or insolvency, the Expiry Date of the Option will be the date immediately preceding the date on which such Option Holder commits such act of bankruptcy.

 

Notwithstanding anything contained in this Plan, in no case will an Option be exercisable after the fifth (5th) anniversary of the Grant Date of the Option.

 

4.3 Exercise Price.  The price at which an Option Holder may purchase a Share upon the exercise of an Option (the "Exercise Price") will be determined by the Board and set forth in the Option Agreement issued in respect of such Option and, in any event, will not be less than the Market Price of the Corporation's Shares calculated as of the Grant Date.  Notwithstanding anything else contained in this Plan, in no case will the Market Price be less than the minimum prescribed by each of the organized trading facilities as would apply to the Grant Date in question.

 

4.4 Vesting.  The date or dates on and after which a particular Option, or part thereof, may be exercised will be determined by the Board and set forth in the Option Agreement issued in respect of such Option. In any event, all Options will be vested gradually and evenly over a period of at least eighteen (18) months, on a quarterly basis.

 

4.5 Additional Terms.  Subject to all applicable Securities Laws of all applicable Regulatory Authorities, the Board may attach other terms and conditions to the grant of a particular Option, such terms and conditions to be referred to in the Option Agreement at the 

 

  

- 11 -

  

time of grant.  These terms and conditions may include, but are not necessarily limited to, the following:

 

	
(a)  

	
providing that an Option expires on a date other than as provided for herein;

 

	
(b)  

	
providing that a portion or portions of an Option vest after certain periods of time or upon the occurrence of certain events, or expire after certain periods of time or upon the occurrence of certain events;

 

	
(c)  

	
providing that an Option be exercisable immediately, in full, notwithstanding that it has vesting provisions, upon the occurrence of certain events, such as a friendly or hostile take-over bid for the Corporation; and

 

	
(d)  

	
providing that an Option issued to, held by or exercised by an Option Holder who is a citizen or resident of the United Sates of America, and otherwise meeting the statutory requirements, be treated as an "Incentive Stock Option" as that term is defined for purposes of the United States of America Internal Revenue Code of 1986, as amended.

 

4.6 Non-Transferability of Options.  The Options granted hereunder are not assignable, transferable or negotiable (whether by operation of law or otherwise) and may not be assigned or transferred, provided however that the Personal Representative of an Option Holder may, to the extent permitted by Section 5.1 of this Plan, exercise the Option within the Exercise Period.  Upon any attempt to assign, transfer, negotiate, pledge, hypothecate or otherwise dispose of or transfer an Option contrary to this Section 4.6 of this Plan, or upon the levy of any attachment or similar process upon an Option, the Option and all rights, benefits and privileges arising thereunder or therefrom, at the sole discretion and election of the Board, shall cease and terminate and be of no further force or affect whatsoever.

 

4.7 No Rights as Shareholders.  An Option Holder shall not have any rights as a shareholder of the Corporation with respect to any of the Shares covered by such Option until the date of issuance of a certificate for Shares upon the due exercise of such Option, in full or in part, and then only with respect to the Shares represented by such certificate or certificates.  Without in any way limiting the generality of the foregoing, no adjustment shall be made for dividends or other rights for which the record date is prior to the date such share certificate is issued.

 

ARTICLE 5

EXERCISE OF OPTION

 

5.1 Exercise of Option.  An Option may be exercised only by the Option Holder or the Personal Representative of the Option Holder. Subject to the provisions of this Plan, an Option Holder or the Personal Representative of an Option Holder may exercise an Option in whole or in part at any time or from time to time during the Exercise Period up to 5:00 p.m. (Montréal time) on the Expiry Date by delivering to the Secretary of the Corporation an Exercise Notice indicating the number of Shares to be purchased pursuant to the exercise of the Option, the applicable Option Agreement and a certified cheque or bank draft payable to "Neptune 

 

  

- 12 -

  

Technologies & Bioressources Inc." in an amount equal to the aggregate Exercise Price of the Shares to be purchased pursuant to the exercise of the Option.

 

5.2 Issue of Share Certificates.  As soon as practicable following the receipt of the Exercise Notice and the certified cheque or bank draft referred to in Section 5.1 above, the Board will cause to be delivered to the Option Holder a certificate for the Shares so purchased. If the number of Shares so purchased is less than the number of Shares subject to the Option Agreement, the Option Holder will surrender the Option Agreement to the Corporation and the Board will forward a new Option Agreement to the Option Holder concurrently with delivery of the Share certificate for the balance of Shares available under the Option.

 

5.3 Condition of Issue.  The Options and the issue of Shares by the Corporation pursuant to the exercise of Options are subject to the terms and conditions of this Plan and compliance with the rules and policies of all applicable Regulatory Authorities to the granting of such Options and to the issuance and distribution of such Shares, and to all applicable Securities Laws. The Option Holder agrees to comply with all such laws, regulations, rules and policies and agrees to furnish to the Corporation any information, reports or undertakings required to comply with and to fully cooperate with the Corporation in complying with such laws, regulations, rules and policies. Notwithstanding any of the provisions contained in this Plan or in any Option, the Corporation's obligation to issue Shares to an Option Holder pursuant to the exercise of any Option granted under the Plan shall be subject to:

 

	
(a)  

	
completion of such registration or other qualification of such Shares or obtaining approval of such Regulatory Authority as the Corporation shall determine to be necessary or advisable in connection with the authorization, issuance or sale thereof;

 

	
(b)  

	
the admission of such Shares to listing on any stock exchange on which the Shares may then be listed;

 

	
(c)  

	
the receipt from the Option Holder of such representations, warranties, agreements and undertakings, as the Corporation determines to be necessary or advisable in order to safeguard against the violation of the Securities Laws of any jurisdiction; and

 

	
(d) 

	
the satisfaction of any conditions on exercise prescribed pursuant to this Plan.

 

5.4 Blackout Period.  If an Option expires during, or within five business days after, a trading black-out period imposed by the Corporation to restrict trades in the Corporation’s securities, then, notwithstanding any other provision of the Plan, the Option shall expire ten business days after the trading black-out period is lifted by the Corporation.

 

ARTICLE 6

AMENDMENT AND TERMINATION

 

6.1 Amendment Without Shareholder Approval.  The Board may amend, suspend or discontinue the Plan, and amend or discontinue any Options granted under the Plan, at any time without shareholder approval. Without limiting the foregoing, the Board is specifically 

 

  

- 13 -

  

authorized to amend the terms of the Plan, and the terms of any Options granted under the Plan, without obtaining shareholder approval, to:

 

	
(a)  

	
amend the vesting provisions;

 

	
(b)  

	
amend the termination provisions, except as otherwise provided in Section 6.3 (b) hereof;

 

	
(c)  

	
amend the eligibility requirements of eligible Directors, Employees or Consultants which would have the potential of broadening or increasing Insider participation;

 

	
(d)  

	
add any form of financial assistance;

 

	
(e)  

	
amend a financial assistance provision which is more favourable to Directors, Employees or Consultants;

 

	
(f)  

	
add a cashless exercise feature, payable in cash or securities, whether or not the feature provides for a full deduction of the number of underlying Shares from the reserved Shares;

 

	
(g)  

	
add a deferred or restricted share unit or any other provision which results in Directors, Employees or Consultants receiving securities while no cash consideration is received by the Corporation; and

 

	
(h)  

	
make other amendments of a housekeeping nature or to comply with the requirements of any Regulatory Authority.

 

6.2 Amendment with Shareholder Approval.  Notwithstanding Section 6.1, no amendments to the Plan to:

 

	
(a)  

	
increase the number of Shares reserved for issuance under the Plan (including a change from a fixed maximum number of shares to a fixed maximum percentage of Shares);

 

	
(b)  

	
change the manner of determining the Exercise Price; or

 

	
(c)  

	
increase the aggregate number of Shares in respect of which Options have been granted and remain outstanding so that such number of Shares, when taken together with all of the Company’s Security Based Compensation Arrangements then either in effect or proposed, shall at any time be such as to result in:

 

	 	
(i) 

	
the number of Shares reserved for issuance to Insiders pursuant to stock options exceeding 10% of the issued and outstanding Shares; or

 

	 	
(ii) 

	
the issuance to Insiders pursuant to stock options, within a one-year period, of a number of Shares exceeding 10% of the issued and outstanding Shares;

 

  

- 14 -

  

 

	
(d)  

	
amend the amending provisions of Sections 6.1 to 6.3 of this Plan

 

shall be made without obtaining approval of the shareholders in accordance with the requirements of the Exchange.

 

6.3 Amendment of Insider Options. Notwithstanding Section 6.1, no amendments to granted Options to:

 

	
(a)  

	
reduce the Exercise Price for the benefit of Insiders; or

 

	
(b)  

	
extend the termination date for the benefit of Insiders, other than in accordance with Section 5.4 hereof;

 

shall be made without obtaining approval of the shareholders in accordance with the requirements of the Exchange; and no action shall be taken with respect to granted Options without the consent of the Option Holder, unless the Board determines that such action does not materially alter or impair such Option.

 

6.4 Options Granted Prior to Termination.  No amendment, suspension or discontinuance of the Plan or of any granted Option may contravene the requirements of the Exchange or any securities commission or regulatory body to which the Plan or the Corporation is now or may hereafter be subject to. Termination of the Plan shall not affect the ability of the Board to exercise the powers granted to it hereunder with respect to Options granted under the Plan prior to the date of such termination.

 

6.5 Retrospective Amendment.  The Board may from time to time retrospectively amend this Plan and, with the consent of the affected Option Holders, retrospectively amend the terms and conditions of any Options that have been previously granted.

 

6.6 Sale of Corporation, Extension of Expiration Date, Non-Applicability of Termination of Employment Provisions.  Notwithstanding anything contained to the contrary in this Plan or in any resolution of the Board in implementation thereof:

 

	
(a)  

	
in the event the Corporation proposes to amalgamate, merge or consolidate with any other corporation (other than a wholly-owned Subsidiary) or to liquidate, dissolve or wind-up, or in the event an offer to purchase or repurchase the Shares of the Corporation or any part thereof shall be made to all or substantially all holders of Shares of the Corporation, the Corporation shall have the right, upon written notice thereof to each Option Holder holding Options under the Plan, to permit the exercise of all such Options within the twenty (20) day period next following the date of such notice and to determine that upon the expiration of such twenty (20) day period, all rights of the Option Holders to such Options or to exercise same (to the extent not theretofore exercised) shall ipso facto terminate and cease to have further force or effect whatsoever;

 

	
(b)  

	
in the event of the sale by the Corporation of all or substantially all of the assets of the Corporation as an entirety or substantially as an entirety so that the Corporation shall cease to operate as an active business, any outstanding Option

 

  

- 15 -

  

	
 

	
may be exercised as to all or any part of the Optioned Shares in respect of which the Option Holder would have been entitled to exercise the Option in accordance with the provisions of the Plan at the date of completion of any such sale at any time up to and including, but not after the earlier of: (i) the close of business on that date which is thirty (30) days following the date of completion of such sale; and (ii) the close of business on the Expiry Date of the Option; but the Option Holder shall not be entitled to exercise the Option with respect to any other Shares;

 

	
(c)  

	
subject to the rules of any relevant Regulatory Authority, the Board may, by resolution, extend the Expiration Date of any Option.  The Board shall not, in the event of any such advancement or extension, be under any obligation to advance or extend the date on or by which Options may be exercised by any other Option Holder; and

 

	
(d)  

	
the Board may, by resolution, but subject to requirements of applicable Regulatory Authorities and Securities Laws, decide that any of the provisions hereof concerning the effect of termination of the Option Holder's employment shall not apply to any Option Holder for any reason acceptable to the Board.

 

Notwithstanding the provisions of this Section 6.6, should changes be required to the Plan by any Regulatory Authority of any jurisdiction to which this Plan or the Corporation now is or hereafter becomes subject, such changes shall be made to the Plan as are necessary to conform with such requirements and, if such changes are approved by the Board, the Plan, as amended, shall be filed with the records of the Corporation and shall remain in full force and effect in its amended form as of and from the date of its adoption by the Board.

 

6.7 Regulatory Authority Approval.  This Plan and any amendments hereto are subject to all necessary approvals of the applicable Regulatory Authorities.

 

6.8 Agreement.  The Corporation and every Option granted hereunder will be bound by and subject to the terms and conditions of this Plan. By accepting an Option granted hereunder, the Option Holder has expressly agreed with the Corporation to be bound by the terms and conditions of this Plan.

 

6.9 Effective Date of Plan.  Upon approval by the shareholders of the Corporation in accordance with the QBCA, and by acceptance by the Exchange (if the Shares are listed or posted on an Exchange and such acceptance is required), the amendments to this Plan made on May 9, 2012 shall be deemed to be effective as of the Effective Date.  Any Options granted prior to such approval and acceptance(s), that exceed the previous number of Options available for grant, shall be conditional upon such approval and acceptance(s) being given and no such Options may be exercised unless such approval and acceptance is given.

 

6.10 Governing Law.  This Plan and all matters to which reference is made herein shall be governed by and interpreted in accordance with the laws of the Province of Québec and the federal laws of Canada applicable therein.

 

  

- 16 -

  

ARTICLE 7

U.S. TAXPAYERS

 

7.1 Provisions for U.S. Taxpayers.  Options granted under this Plan to U.S. Taxpayers may be nonqualified stock options or incentive stock options intended to qualify under Section 422 (“ISOs”) of the United States Internal Revenue Code of 1986 and the applicable authority thereunder (the “Code”). Each Option shall be designated in the Option Agreement as either an ISO or a non-qualified stock option. “U.S. Taxpayer” means a Person who is a U.S. citizen, U.S. permanent resident or U.S. tax resident for the purposes of the Code whose purchase of Shares under this Plan would be subject to U.S. taxation under the Code. Such Person shall be considered a U.S. Taxpayer solely with respect to such options.

 

7.2 ISOs.  The maximum number of Options that may be granted as ISOs is equal to the maximum number of Shares issuable under Section 3.3. The terms and conditions of any ISOs granted hereunder, including the eligible recipients of ISOs, shall be subject to the provisions of Section 422 of the Code, and the terms, conditions, limitations and administrative procedures established by the Board from time to time in accordance with this Plan. At the discretion of the Board, ISOs may be granted to any Employee of the Corporation, its parent or any subsidiary of the Corporation, as such terms are defined in Sections 424(e) and (f) of the Code.

 

7.3 ISO Grants to 10% Shareholders.  Notwithstanding anything to the contrary in this Plan, if an ISO is granted to a Person who owns shares representing more than ten percent of the voting power of all classes of shares of the Corporation or of a subsidiary or parent, as such terms are defined in Section 424(e) and (f) of the Code, the term of the Option shall not exceed five years from the time of grant of such Option and the Exercise Price shall be at least 110 percent (110%) of the Market Price (at the time of grant) of the Shares subject to the Option.

 

7.4 $100,000 Per Year Limitation for ISOs.  To the extent the aggregate Market Price (determined at the time of grant) of the Shares for which ISOs are exercisable for the first time by any Person during any calendar year (under all plans of the Corporation) exceeds $100,000, such excess ISOs shall be treated as nonqualified stock options.

 

7.5 Disqualifying Dispositions.  Each Person awarded an ISO under this Plan shall notify the Corporation in writing immediately after the date he or she makes a disqualifying disposition of any Shares acquired pursuant to the exercise of such ISO. A disqualifying disposition is any disposition (including any sale) of Shares before the later of (i) two years after the time of grant of the ISO or (ii) one year after the date the Person acquired the Shares by exercising the ISO. The Corporation may, if determined by the Board and in accordance with procedures established by it, retain possession of any Shares acquired pursuant to the exercise of an ISO as agent for the applicable Person until the end of the period described in the preceding sentence, subject to complying with any instructions from such Person as to the sale of such Share.

 

7.6 Section 409A.  Any Options granted to U.S. Taxpayers shall be limited to Employees or Consultants providing services to the Corporation or to an affiliate which is an “eligible issuer”, as defined in final Treas. Reg. 1.409A-1(b)(iii) (this includes corporate 

 

  

- 17 -

  

subsidiaries in which the Corporation has a controlling interest).

 

	
(a)  

	
No extension of term of an Option shall extend beyond the latest date that the right could have expired by its original terms.  However, an extension to no more than 30 days following a blackout to comply with applicable law is not an extension for purposes of this provision.

 

	
(b)  

	
Any replacement options issued under Section 3.5 or 6.6 of this Plan shall comply with U.S. Treas. Reg. 1.424-1 as if the Option were a incentive stock option (ISO) so that the ratio of the Exercise Price to the fair market value of Shares subject to the Options immediately after the replacement may not be greater than the ratio of the Exercise Price to the fair market value of Shares subject to the Options immediately before the replacement.

 

Approved by the board of directors on May 9, 2012.

 

Approved by the shareholders on June 21, 2012.

 

 

	 	
Neptune Technologies & Bioressources Inc.

	 	 	 
	 	
By:

	
/s/ Henri Harland

	 	 	
Name: Henri Harland

	 	 	
Title: President and Chief Executive Officer

 

 

 

 

- 18 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00205-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00205-of-00352.parquet"}]]